yemenjmedYemen Journal of MedicinecoVolume 1 Issue 1MultidisciplinaryEnglishJanuary - June 2022NNY20250325ArticleAssociation of vitamin D deficiency with dyslipidemia, glycemic control, and microalbuminuria in patients with Type 2 diabetes mellitus in QatarEnglishY1721GowriKaruppasamy1EnglishNShaikha AlShokri2EnglishYAseelSukik3EnglishYMohamed ElmudathirOsman4EnglishY10.32677/yjm.v1i1.3292Background: Emerging data found that Type 2 diabetes mellitus (T2DM) is associated with Vitamin D deficiency at various frequencies. This study aims to estimate the prevalence of Vitamin D deficiency in T2DM patients in Qatar and the correlation between Vitamin D deficiency and other variables such as dyslipidemia, glycemic control, and microalbuminuria. Methods: This retrospective cross-sectional analytical study was conducted in the medical outpatient clinic at Hamad General Hospital. The study involved adult patients (≥18 years) with T2DM. The study covered patients admitted between January 1, 2018, and July 31, 2018. Ethical approval was obtained from the Medical Research Committee. Results: We recruited 400 subjects with T2DM. Their mean age was 58.97±10.32 years, and the majority were women (52.0%) and Arabs (69.5%). The mean duration of Type 2 diabetes diagnosis was 14.94±8.99 years. The prevalence of Vitamin D deficiency was 29.5%. A comparison between Vitamin D deficiency and non-vitamin D deficiency groups showed a statistically significant difference in terms of fasting blood (FB) sugar (pEnglishDyslipidemia, Glycemic control, Microalbuminuria, Type 2 diabetes mellitus, Vitamin Dhttps://www.yemenjmed.com/admin/abstract?id=19References16191. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843.2. Awad SF, Oand;rsquo;Flaherty M, Critchley J, et al. Forecasting the burden of Type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach. Diabetes Res Clin Pract 2018;137:100-8.3. Pittas AG, Lau J, Hu FB, et al. The role of Vitamin D and calcium in Type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.4. Holick MF. Vitamin D: Extraskeletal health. Endocrinol Metab Clin North Am 2010;39:381-400.5. Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 2013;12:976-89.6. Lips P, Eekhoff M, van Schoor N, et al. Vitamin D and Type 2 diabetes. J Steroid Biochem Mol Biol 2017;173:280-5.7. Pittas AG, Jorde R, Kawahara T, et al. Vitamin D supplementation for prevention of Type 2 diabetes mellitus: To D or not to D? J Clin Endocrinol Metab 2020;105:3721-33.8. Shaafie IA, Hesham RA, Basha AA. Vitamin D status in Type 2 diabetic patients and its association with glycemic control, lipids and microalbuminuria: A pilot study. GMJ ASM 2013;2:S6-13.9. Aljack HA, Abdalla MK, Idris OF, et al. Vitamin D deficiency increases risk of nephropathy and cardiovascular diseases in Type 2 diabetes mellitus patients. J Res Med Sci 2019;24:47.10. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerularand;nbsp;filtration rate. Ann Intern Med 2009;150:604-12.11. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of Vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote Vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:373-8.12. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007;103:620-5.13. Gannage-Yared MH, Chemali R, Yaacoub N, et al. Hypovitaminosis D in a sunny country: Relation to lifestyle and bone markers. J Bone Miner Res 2000;15:1856-62.14. Michos ED. Vitamin D deficiency and the risk of incident Type 2 diabetes. Future Cardiol 2009;5:15-8.15. Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab 2005;31:318-25.16. Bell NH, Greene A, Epstein S, et al. Evidence for alteration of Vitamin D-endocrine system in Blacks. J Clin Invest 1985;76:470-3.17. Rolim MC, Santos BM, Conceiand;ccedil;and;atilde;o G, et al. Relationship between Vitamin D status, glycemic control and cardiovascular risk factors in Brazilians with Type 2 diabetes mellitus. Diabetol Metab Syndr 2016;8:77.18. Anyanwu AC, Olopade OB, Onung SI, et al. Serum Vitamin D levels in persons with Type 2 diabetes mellitus in Lagos, Nigeria. Int J Diabetes Clin Res 2020;7:133.19. Karau PB, Kirna B, Amayo E, et al. The prevalence of Vitamin D deficiency among patients with Type 2 diabetes seen at a referral hospital in Kenya. Pan Afr Med J 2019;34:38.20. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral Vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial. BMJ 2003;326:469-75.21. Karhapand;auml;and;auml; P, Pihlajamand;auml;ki J, Pand;ouml;rsti I, et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 2010;268:604-61.22. Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arteriosc Thromb 1992;12:671-4.23. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third national health and nutrition examination survey. Arch Intern Med 2007;167:1159-65.24. Wang Y, Si S, Liu J, et al. The associations of serum lipids with Vitamin D status. PLoS One 2016;11:e0165157.25. Vaskonen T, Mervaala E, Sumuvuori V, et al. Effects of calcium and plant sterols on serum lipids in obese Zucker rats on a low-fat diet. Br J Nutr 2007;87:239-45.26. Balla DI, Abdalla AM, Elrayah ZA, et al. The association of 25(OH) Vitamin D level with glycemic control and nephropathy complication in Sudanese with Type 2 diabetes. Int J Med Res Health Sci 2018;7:62-8.27. Fiscella KA, Winters PC, Ogedegbe G. Vitamin D and racial disparity in albuminuria: NHANES 2001-2006. Am J Hypertens 2011;24:1114-20.28. Gembillo G, Cernaro V, Salvo A, et al. Role of Vitamin D status in diabetic patients with renal disease. Medicina (Kaunas) 2019;55:273.29. de Boer IH, Sachs MC, Cleary PA, et a1. Circulating Vitamin D metabolites and kidney disease in Type 1 diabetes. J Clin Endocrinol Metab 2012;97:4780-8.30. Joergensen C, Hovind P, Schmedes A, et a1. Vitamin D levels, microvascular complications, and mortality in Type l diabetes. Diabetes Care 2011;34:1081-5.31. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P, et al. Vitamin D levels and mortality in Type 2 diabetes. Diabetes Care 2010;33:2238-22.